{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:32:58Z","timestamp":1789914778899,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.lpm.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T10:45:51Z","timestamp":1540377951000},"page":"899-912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Strat\u00e9gies de sevrage de benzodiaz\u00e9pines en ambulatoire. Revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"47","author":[{"given":"Fran\u00e7ois","family":"Naccache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Vorspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2018.10.007_bib0210","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1001\/jama.1989.03430230088031","article-title":"Benzodiazepines of long and short elimination half-life and the risk of hip fracture","volume":"262","author":"Ray","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2018.10.007_bib0215","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/archinte.1995.00430160149015","article-title":"Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life","volume":"155","author":"Herings","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2018.10.007_bib0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.lpm.2018.10.007_bib0225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.comppsych.2003.12.007","article-title":"Determination of the main risk factors for benzodiazepine dependence using a multivariate and multidimensional approach","volume":"45","author":"Kan","year":"2004","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.007_bib0230","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0013-7006(07)91556-0","article-title":"Anxiety and depressive disorders in 4425\u00a0long term benzodiazepine users in general practice","volume":"33","author":"P\u00e9lissolo","year":"2007","journal-title":"Encephale"},{"key":"10.1016\/j.lpm.2018.10.007_bib0235","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00023210-199810060-00004","article-title":"Withdrawal reactions after stopping hypnotics in patients with insomnia","volume":"10","author":"Lader","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.lpm.2018.10.007_bib0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.lpm.2018.10.007_bib0245","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S1355617705050332","article-title":"An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use","volume":"11","author":"Barker","year":"2005","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.lpm.2018.10.007_bib0250","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2018.10.007_bib0255","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer's disease: case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2018.10.007_bib0260","series-title":"Arr\u00eat des benzodiaz\u00e9pines et m\u00e9dicaments apparent\u00e9s\u00a0: d\u00e9marche du m\u00e9decin traitant en ambulatoire","author":"Rapport d\u2019\u00e9laboration","year":"2015"},{"key":"10.1016\/j.lpm.2018.10.007_bib0265","series-title":"M\u00e9dicaments psychotropes\u00a0: consommations et pharmacod\u00e9pendances","year":"2012"},{"key":"10.1016\/j.lpm.2018.10.007_bib0270","series-title":"Etat des lieux de la consommation des benzodiaz\u00e9pines en France","author":"ANSM","year":"2013"},{"key":"10.1016\/j.lpm.2018.10.007_bib0275","series-title":"The effects of tranquillization: benzodiazepine use in Canada. Minister of National Health and Welfare","author":"Cooperstock","year":"1982"},{"key":"10.1016\/j.lpm.2018.10.007_bib0280","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0269881111405360","article-title":"Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial","volume":"26","author":"Hadley","year":"2012","journal-title":"J Psychopharmacol (Oxford)"},{"key":"10.1016\/j.lpm.2018.10.007_bib0285","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1440-1819.2006.01565.x","article-title":"Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic","volume":"60","author":"Nakao","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.lpm.2018.10.007_bib0290","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/archinte.159.20.2456","article-title":"Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach","volume":"159","author":"Garfinkel","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2018.10.007_bib0295","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/bcp.12294","article-title":"Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial","volume":"77","author":"L\u00e4hteenm\u00e4ki","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lpm.2018.10.007_bib0300","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archpsyc.1991.01810290060012","article-title":"Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome","volume":"48","author":"Schweizer","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.007_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050798","article-title":"Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome","volume":"141","author":"Rickels","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.lpm.2018.10.007_bib0310","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1192\/bjp.168.4.457","article-title":"A controlled trial of dothiepin and placebo in treating benzodiazepine withdrawal symptoms","volume":"168","author":"Tyrer","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.007_bib0315","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ageing\/afp255","article-title":"One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons","volume":"39","author":"Salonoja","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.lpm.2018.10.007_bib0320","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/qshc.6.1.14","article-title":"Randomised controlled trial of reminders to enhance the impact of audit in general practice on management of patients who use benzodiazepines","volume":"6","author":"Baker","year":"1997","journal-title":"Qual Health Care"},{"key":"10.1016\/j.lpm.2018.10.007_bib0325","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1176\/appi.ajp.161.2.332","article-title":"Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia","volume":"161","author":"Morin","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.007_bib0330","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1192\/bjp.182.6.498","article-title":"Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial","volume":"182","author":"Voshaar","year":"2003","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.007_bib0335","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1192\/bjp.bp.105.012039","article-title":"Long-term outcome of two forms of randomised benzodiazepine discontinuation","volume":"188","author":"Oude Voshaar","year":"2006","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.lpm.2018.10.007_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpp.556","article-title":"Cognitive-behavioural, pharmacological and psychosocial predictors of outcome during tapered discontinuation of benzodiazepine","volume":"15","author":"O\u2019Connor","year":"2008","journal-title":"Clin Psychol Psychother"},{"key":"10.1016\/j.lpm.2018.10.007_bib0345","first-page":"1015","article-title":"Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial","volume":"169","author":"Baillargeon","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.lpm.2018.10.007_bib0350","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1192\/bjp.bp.113.134650","article-title":"Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care","volume":"204","author":"Vicens","year":"2014","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.007_bib0355","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3399\/bjgp16X683485","article-title":"Efficacy of two interventions on the discontinuation of benzodiazepines in long-term users: 36-month follow-up of a cluster randomised trial in primary care","volume":"66","author":"Vicens","year":"2016","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.lpm.2018.10.007_bib0360","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.lpm.2018.10.007_bib0365","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1360-0443.2008.02141.x","article-title":"Long-term effectiveness of computer-generated tailored patient education on benzodiazepines: a randomized controlled trial","volume":"103","author":"Ten Wolde","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.lpm.2018.10.007_bib0370","first-page":"958","article-title":"Withdrawal from long-term benzodiazepine use: randomised trial in family practice","volume":"56","author":"Vicens","year":"2006","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.lpm.2018.10.007_bib0375","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1192\/bjp.189.3.213","article-title":"Strategies for discontinuing long-term benzodiazepine use: meta-analysis","volume":"189","author":"Voshaar","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.007_bib0380","first-page":"CD005194","article-title":"Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings","volume":"3","author":"Denis","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2018.10.007_bib0385","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2146\/ajhp160712","article-title":"Pregabalin as adjunctive therapy in benzodiazepine discontinuation","volume":"75","author":"Caniff","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.lpm.2018.10.007_bib0390","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1360-0443.2008.02364.x","article-title":"Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis","volume":"104","author":"Parr","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.lpm.2018.10.007_bib0395","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1192\/bjp.bp.113.126003","article-title":"Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials","volume":"204","author":"Gould","year":"2014","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.007_bib0400","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1517\/14740338.2014.925444","article-title":"Risk versus risk: a review of benzodiazepine reduction in older adults","volume":"13","author":"Paquin","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.lpm.2018.10.007_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13607863.2017.1423030","article-title":"Interventions to improve benzodiazepine tapering success in the elderly: a systematic review","author":"Dou","year":"2018","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.lpm.2018.10.007_bib0205","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.3399\/bjgp11X593857","article-title":"Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis","volume":"61","author":"Mugunthan","year":"2011","journal-title":"Br J Gen Pract"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218303853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218303853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T16:09:40Z","timestamp":1543421380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498218303853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0755498218303853"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2018.10.007","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strat\u00e9gies de sevrage de benzodiaz\u00e9pines en ambulatoire. Revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}